ESLA·297584104·US·equity·Healthcare - Biotechnology-13D/G
ESLA (ESTRELLA IMMUNOPHARMA INC) is held by 12 institutional investors as of Q1 2026. Largest holders: WELLS FARGO & COMPANY/MN ($280,251), GEODE CAPITAL MANAGEMENT, LLC ($166,933), RENAISSANCE TECHNOLOGIES LLC ($66,563). Net institutional sentiment: Mixed.
See how ESLA's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer